Cite
HARVARD Citation
Richards, C. et al. (2018). A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. Journal of clinical psychopharmacology. 38 (4), p. . [Online].